general tiredness
Vomiting
The Food and Drug Administration (FDA) has approved it to treat the following conditions
constipation
dizziness or vertigo
If you stop taking Cymbalta suddenly, you may experience withdrawal symptoms, including nausea, dizziness, headache, irritability, and tingling skin
Overdose
Electric shock sensations
It is important to taper off
3%) “pin-and-needles” or burning feeling on skin, called paresthesia (2
Some common signs and symptoms of a Cymbalta overdose may include: 1
numbness
Cymbalta was designed as a pharmaceutical that was made to combat these neurochemical processes
Cymbalta is a safe, effective treatment for depression and anxiety disorders
Some research suggests that an estimated 44% of people who discontinue
Duloxetine may cause some teenagers and young adults to be agitated, irritable, or display other abnormal behaviors
Duloxetine is also used to treat fibromyalgia (muscle pain and stiffness) and chronic (long-lasting) pain that is related to muscles and bones
It belongs to the class of drugs known as serotonin and norepinephrine reuptake inhibitors (SNRIs)
If you stop taking Cymbalta, or you start to wean off it, it’s important to know how your body may react to the withdrawal
constipation
My depression continues and am going back to prozac
It works by preventing the body from reabsorbing two neurotransmitters: serotonin and norepinephrine
If you have severe symptoms, immediately call 911 (or your local emergency number) or go to the nearest emergency room
Fibromyalgia is a long-term condition that causes widespread pain and fatigue
However, withdrawal symptoms from Cymbalta are so common that doctors have given the symptoms the term: Cymbalta Discontinuation Syndrome
Neurotransmitters act throughout the body, and you may experience physical as well as mental effects when you stop taking antidepressants or lower the dose too fast
increase risk of falls, especially in elderly
However, higher doses of duloxetine are associated with more adverse effects without more positively impacting symptom reduction